Hodgkin Lymphoma News and Research

RSS
New category of immunotherapy appears safe to use in patients with both cancer and HIV

New category of immunotherapy appears safe to use in patients with both cancer and HIV

FDA grants accelerated approval to new treatment for mantle cell lymphoma

FDA grants accelerated approval to new treatment for mantle cell lymphoma

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

New CAR-T cell therapy offers effective option for certain blood cancer patients

New CAR-T cell therapy offers effective option for certain blood cancer patients

Novel gene expression signature assay could help enhance lymphoma management

Novel gene expression signature assay could help enhance lymphoma management

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Study identifies late effects that may interfere with work status of young adult cancer survivors

Study identifies late effects that may interfere with work status of young adult cancer survivors

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

Infographic displays facts and information about stem cells, cord blood

Infographic displays facts and information about stem cells, cord blood

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Differential RNA splicing may play role in prostate cancer disparities in African-American men

Differential RNA splicing may play role in prostate cancer disparities in African-American men

FDA authorizes marketing of test to aid in diagnoses of serious cancers

FDA authorizes marketing of test to aid in diagnoses of serious cancers

Researchers suggest new strategy to identify germline mutations in men with prostate cancer

Researchers suggest new strategy to identify germline mutations in men with prostate cancer

Proteins impeding antitumor immunity could be 'Achilles heel' of some cancers

Proteins impeding antitumor immunity could be 'Achilles heel' of some cancers

AMSBIO introduce range of cancer exosome samples

AMSBIO introduce range of cancer exosome samples

Combination therapy has complete response rate in children, young adults with Hodgkin lymphoma

Combination therapy has complete response rate in children, young adults with Hodgkin lymphoma

Study finds steady decline in severe health problems for childhood cancer survivors

Study finds steady decline in severe health problems for childhood cancer survivors